Industry: Chemical & Material
Published Date: 2025-11-02
Pages: 97 Pages
Report ld: 5370964
Request Sample
Customized Report
Paracetamol and Acetaminophen API Market Size(US$)

CAGR 2025-2031
2.5%
Market Size,2031
USD 1,647
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Paracetamol and Acetaminophen API market size was US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Paracetamol and Acetaminophen API market competitiveness, regional economic performance, and supply chain configurations.
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Paracetamol and Acetaminophen API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Paracetamol and Acetaminophen API market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Granules in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Granules Drug in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Paracetamol and Acetaminophen API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Paracetamol and Acetaminophen API Product Scope
1.2 Paracetamol and Acetaminophen API by Type
1.2.1 Global Paracetamol and Acetaminophen API Sales by Type (2020 & 2024 & 2031)
1.2.2 Powder
1.2.3 Granules
1.3 Paracetamol and Acetaminophen API by Application
1.3.1 Global Paracetamol and Acetaminophen API Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Tablet Drug
1.3.3 Granules Drug
1.3.4 Oral Solution
1.3.5 Others
1.4 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts (2020-2031)
1.4.1 Global Paracetamol and Acetaminophen API Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Paracetamol and Acetaminophen API Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Paracetamol and Acetaminophen API Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Paracetamol and Acetaminophen API Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Paracetamol and Acetaminophen API Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Paracetamol and Acetaminophen API Sales Market Share by Region (2020-2025)
2.2.2 Global Paracetamol and Acetaminophen API Revenue Market Share by Region (2020-2025)
2.3 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Paracetamol and Acetaminophen API Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Paracetamol and Acetaminophen API Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Paracetamol and Acetaminophen API Market Size and Prospective (2020-2031)
2.4.2 Europe Paracetamol and Acetaminophen API Market Size and Prospective (2020-2031)
2.4.3 China Paracetamol and Acetaminophen API Market Size and Prospective (2020-2031)
2.4.4 Japan Paracetamol and Acetaminophen API Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Paracetamol and Acetaminophen API Historic Market Review by Type (2020-2025)
3.1.1 Global Paracetamol and Acetaminophen API Sales by Type (2020-2025)
3.1.2 Global Paracetamol and Acetaminophen API Revenue by Type (2020-2025)
3.1.3 Global Paracetamol and Acetaminophen API Price by Type (2020-2025)
3.2 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Paracetamol and Acetaminophen API Sales Forecast by Type (2026-2031)
3.2.2 Global Paracetamol and Acetaminophen API Revenue Forecast by Type (2026-2031)
3.2.3 Global Paracetamol and Acetaminophen API Price Forecast by Type (2026-2031)
3.3 Different Types Paracetamol and Acetaminophen API Representative Players
4 Global Market Size by Application
4.1 Global Paracetamol and Acetaminophen API Historic Market Review by Application (2020-2025)
4.1.1 Global Paracetamol and Acetaminophen API Sales by Application (2020-2025)
4.1.2 Global Paracetamol and Acetaminophen API Revenue by Application (2020-2025)
4.1.3 Global Paracetamol and Acetaminophen API Price by Application (2020-2025)
4.2 Global Paracetamol and Acetaminophen API Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Paracetamol and Acetaminophen API Sales Forecast by Application (2026-2031)
4.2.2 Global Paracetamol and Acetaminophen API Revenue Forecast by Application (2026-2031)
4.2.3 Global Paracetamol and Acetaminophen API Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Paracetamol and Acetaminophen API Application
5 Competition Landscape by Players
5.1 Global Paracetamol and Acetaminophen API Sales by Players (2020-2025)
5.2 Global Top Paracetamol and Acetaminophen API Players by Revenue (2020-2025)
5.3 Global Paracetamol and Acetaminophen API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paracetamol and Acetaminophen API as of 2024)
5.4 Global Paracetamol and Acetaminophen API Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Paracetamol and Acetaminophen API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Paracetamol and Acetaminophen API, Product Type & Application
5.7 Global Key Manufacturers of Paracetamol and Acetaminophen API, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Paracetamol and Acetaminophen API Sales by Company
6.1.1.1 North America Paracetamol and Acetaminophen API Sales by Company (2020-2025)
6.1.1.2 North America Paracetamol and Acetaminophen API Revenue by Company (2020-2025)
6.1.2 North America Paracetamol and Acetaminophen API Sales Breakdown by Type (2020-2025)
6.1.3 North America Paracetamol and Acetaminophen API Sales Breakdown by Application (2020-2025)
6.1.4 North America Paracetamol and Acetaminophen API Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Paracetamol and Acetaminophen API Sales by Company
6.2.1.1 Europe Paracetamol and Acetaminophen API Sales by Company (2020-2025)
6.2.1.2 Europe Paracetamol and Acetaminophen API Revenue by Company (2020-2025)
6.2.2 Europe Paracetamol and Acetaminophen API Sales Breakdown by Type (2020-2025)
6.2.3 Europe Paracetamol and Acetaminophen API Sales Breakdown by Application (2020-2025)
6.2.4 Europe Paracetamol and Acetaminophen API Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Paracetamol and Acetaminophen API Sales by Company
6.3.1.1 China Paracetamol and Acetaminophen API Sales by Company (2020-2025)
6.3.1.2 China Paracetamol and Acetaminophen API Revenue by Company (2020-2025)
6.3.2 China Paracetamol and Acetaminophen API Sales Breakdown by Type (2020-2025)
6.3.3 China Paracetamol and Acetaminophen API Sales Breakdown by Application (2020-2025)
6.3.4 China Paracetamol and Acetaminophen API Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Paracetamol and Acetaminophen API Sales by Company
6.4.1.1 Japan Paracetamol and Acetaminophen API Sales by Company (2020-2025)
6.4.1.2 Japan Paracetamol and Acetaminophen API Revenue by Company (2020-2025)
6.4.2 Japan Paracetamol and Acetaminophen API Sales Breakdown by Type (2020-2025)
6.4.3 Japan Paracetamol and Acetaminophen API Sales Breakdown by Application (2020-2025)
6.4.4 Japan Paracetamol and Acetaminophen API Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Information
7.1.2 Mallinckrodt Business Overview
7.1.3 Mallinckrodt Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Mallinckrodt Paracetamol and Acetaminophen API Products Offered
7.1.5 Mallinckrodt Recent Development
7.2 Anqiu Lu'an
7.2.1 Anqiu Lu'an Company Information
7.2.2 Anqiu Lu'an Business Overview
7.2.3 Anqiu Lu'an Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Anqiu Lu'an Paracetamol and Acetaminophen API Products Offered
7.2.5 Anqiu Lu'an Recent Development
7.3 Granules India
7.3.1 Granules India Company Information
7.3.2 Granules India Business Overview
7.3.3 Granules India Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Granules India Paracetamol and Acetaminophen API Products Offered
7.3.5 Granules India Recent Development
7.4 Farmson
7.4.1 Farmson Company Information
7.4.2 Farmson Business Overview
7.4.3 Farmson Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Farmson Paracetamol and Acetaminophen API Products Offered
7.4.5 Farmson Recent Development
7.5 Hebei Jiheng
7.5.1 Hebei Jiheng Company Information
7.5.2 Hebei Jiheng Business Overview
7.5.3 Hebei Jiheng Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Hebei Jiheng Paracetamol and Acetaminophen API Products Offered
7.5.5 Hebei Jiheng Recent Development
7.6 Zhejiang Kangle
7.6.1 Zhejiang Kangle Company Information
7.6.2 Zhejiang Kangle Business Overview
7.6.3 Zhejiang Kangle Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Zhejiang Kangle Paracetamol and Acetaminophen API Products Offered
7.6.5 Zhejiang Kangle Recent Development
7.7 Sri Krishna Pharma
7.7.1 Sri Krishna Pharma Company Information
7.7.2 Sri Krishna Pharma Business Overview
7.7.3 Sri Krishna Pharma Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Sri Krishna Pharma Paracetamol and Acetaminophen API Products Offered
7.7.5 Sri Krishna Pharma Recent Development
7.8 Anhui BBCA Likang
7.8.1 Anhui BBCA Likang Company Information
7.8.2 Anhui BBCA Likang Business Overview
7.8.3 Anhui BBCA Likang Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Anhui BBCA Likang Paracetamol and Acetaminophen API Products Offered
7.8.5 Anhui BBCA Likang Recent Development
7.9 Seqens
7.9.1 Seqens Company Information
7.9.2 Seqens Business Overview
7.9.3 Seqens Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Seqens Paracetamol and Acetaminophen API Products Offered
7.9.5 Seqens Recent Development
7.10 Atabay
7.10.1 Atabay Company Information
7.10.2 Atabay Business Overview
7.10.3 Atabay Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Atabay Paracetamol and Acetaminophen API Products Offered
7.10.5 Atabay Recent Development
7.11 Anhui Fubore
7.11.1 Anhui Fubore Company Information
7.11.2 Anhui Fubore Business Overview
7.11.3 Anhui Fubore Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Anhui Fubore Paracetamol and Acetaminophen API Products Offered
7.11.5 Anhui Fubore Recent Development
7.12 Changshu Huagang
7.12.1 Changshu Huagang Company Information
7.12.2 Changshu Huagang Business Overview
7.12.3 Changshu Huagang Paracetamol and Acetaminophen API Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Changshu Huagang Paracetamol and Acetaminophen API Products Offered
7.12.5 Changshu Huagang Recent Development
8 Paracetamol and Acetaminophen API Manufacturing Cost Analysis
8.1 Paracetamol and Acetaminophen API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Paracetamol and Acetaminophen API
8.4 Paracetamol and Acetaminophen API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Paracetamol and Acetaminophen API Distributors List
9.3 Paracetamol and Acetaminophen API Customers
10 Paracetamol and Acetaminophen API Market Dynamics
10.1 Paracetamol and Acetaminophen API Industry Trends
10.2 Paracetamol and Acetaminophen API Market Drivers
10.3 Paracetamol and Acetaminophen API Market Challenges
10.4 Paracetamol and Acetaminophen API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 962 million in 2025 and is projected to reach US$ 1065 million, growing at a CAGR of 1.5% from 2026 to 2032.
Published Date: 2026-04-16
Pages: 137
USD 3950.00
(Single User License)
The global Paracetamol and Acetaminophen API market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1065 million by 2032, at a CAGR of 1.5% from 2026 to 2032.
Published Date: 2026-04-16
Pages: 138
USD 2900.00
(Single User License)
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 962 million in 2025 to US$ 1065 million by 2032, at a CAGR of 1.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-16
Pages: 156
USD 4900.00
(Single User License)
The global Paracetamol and Acetaminophen API market size was US$ 962 million in 2025 and is forecast to reach a readjusted size of US$ 1065 million by 2032 with a CAGR of 1.5% during the forecast period 2026-2032.
Published Date: 2026-04-16
Pages: 136
USD 4250.00
(Single User License)
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 1389 million in 2024 to US$ 1647 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Paracetamol and Acetaminophen API was valued at US$ 1389 million in the year 2024 and is projected to reach a revised size of US$ 1647 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 97
USD 2900.00
(Single User License)
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 127
USD 3950.00
(Single User License)
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published Date: 2024-04-12
Pages: 110
USD 4900.00
(Single User License)
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published Date: 2024-01-12
Pages: 96
USD 2900.00
(Single User License)
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published Date: 2024-01-08
Pages: 127
USD 3950.00
(Single User License)
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 962 million in 2025 and is projected to reach US$ 1065 million, growing at a CAGR of 1.5% from 2026 to 2032.
Published: 2026-04-16
Pages: 137
The global Paracetamol and Acetaminophen API market was valued at US$ 962 million in 2025 and is anticipated to reach US$ 1065 million by 2032, at a CAGR of 1.5% from 2026 to 2032.
Published: 2026-04-16
Pages: 138
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 962 million in 2025 to US$ 1065 million by 2032, at a CAGR of 1.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-16
Pages: 156
The global Paracetamol and Acetaminophen API market size was US$ 962 million in 2025 and is forecast to reach a readjusted size of US$ 1065 million by 2032 with a CAGR of 1.5% during the forecast period 2026-2032.
Published: 2026-04-16
Pages: 136
The global Paracetamol and Acetaminophen API market is projected to grow from US$ 1389 million in 2024 to US$ 1647 million by 2031, at a CAGR of 2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Paracetamol and Acetaminophen API was valued at US$ 1389 million in the year 2024 and is projected to reach a revised size of US$ 1647 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-01-16
Pages: 97
The global market for Paracetamol and Acetaminophen API was estimated to be worth US$ 1389 million in 2024 and is forecast to a readjusted size of US$ 1647 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 127
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published: 2024-04-12
Pages: 110
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published: 2024-01-12
Pages: 96
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
Published: 2024-01-08
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now